Effectiveness and cost-effectiveness of telehealthcare for chronic obstructive pulmonary disease: Study protocol for a cluster randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Udsen, Flemming W ^a   Lilholt, Pernille H ^a   Hejlesen, Ole ^a   Ehlers, Lars H ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Chronic obstructive pulmonary disease; Cluster randomized trial; Cost effectiveness; Denmark; Effectiveness; Telemedicine

Indexed keywords

ARTICLE; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DENMARK; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PULSE RATE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TELEHEALTH; TELEHEALTHCARE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; COST BENEFIT ANALYSIS; DEVICES; DISEASE COURSE; ECONOMICS; HEALTH CARE COST; HEALTH STATUS; MICROCOMPUTER; MORTALITY; MULTICENTER STUDY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TELECONSULTATION; TELEMEDICINE; TIME; TREATMENT OUTCOME;

BIOLOGICAL MARKER; OXYGEN;

BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; COMPUTERS, HANDHELD; COST-BENEFIT ANALYSIS; DENMARK; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE PROGRESSION; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REMOTE CONSULTATION; SOFTWARE; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901651314     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-178     Document Type: Article

References (27)

1. Chronic obstructive pulmonary disease (COPD). [http://www.who.int/mediacentre/factsheets/fs315/en/index.html].
2. National Institute of Public Health Eight Diseases Threatening Our Public Health - Prevalence and Development 2005, Copenhagen: , National Institute of Public Health.
3. Løkke A, Fabricius PG, Vestbo J, Marott JLLP. Prevalence of COPD in Copenhagen - results from The Copenhagen City Heart Study. Ugeskr Laeger 2007, 169:3956-3960.
4. COPD in Denmark. [http://www.lunge.dk].
5. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: A systematic review and meta-analysis. J Telemed Telecare 2010, 16:120-127. 10.1258/jtt.2009.090812, 20197355.
6. Jakobsen AS, Laursen LC, Schou L, Emme C, Phanareth KV. Varying effect of telemedicine in the treatment of chronic obstructive pulmonary disease-a systematic review. Ugeskr Laeger 2012, 174:936-942.
7. McLean S, Nurmatov U, Liu JL, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011, 7. CD007718.
8. De Toledo P, Jiménez S, del Pozo F, Roca J, Alonso A, Hernandez C. Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed 2006, 10:567-573. 10.1109/TITB.2005.863877, 16871726.
9. Haesum LKE, Soerensen N, Dinesen B, Nielsen C, Grann O, Hejlesen O, Toft E, Ehlers L. Cost-utility analysis of a telerehabilitation program: A case study of COPD patients. Telemed e-Health 2012, 18:688-692.
10. Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Arch Fam Med 2000, 9:40-45. 10.1001/archfami.9.1.40, 10664641.
11. Koff PB, Jones RH, Cashman JM, Voelkel NF, Vandivier RW. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J 2009, 33:1031-1038. 10.1183/09031936.00063108, 19129289.
12. Pare G, Poba-Nzaou P, Sicotte C, Beaupre A, Lefrancois E, Nault D, Saint-Jules D. Comparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: A randomized controlled trial. Eur Res Telemed 2013, 2:35-47.
13. Vitacca M, Bianchi L, Guerra A, Fracchia C, Spanevello A, Balbi B, Scalvini S. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J 2009, 33:411-418.
14. McLean S, Nurmatov U, Liu JLY, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease: Cochrane Review and meta-analysis. Br J Gen Pract 2012, 62:e739-e749. 10.3399/bjgp12X658269, 3481514, 23211177.
15. Henderson C, Knapp M, Fernández J, Beecham J, Hirani S, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, Doll H, Fitzpatrick R, Steventon A, Bardsley M, Hendy JSN. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013, 346:f1035. 10.1136/bmj.f1035, 23520339.
16. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Fitzpatrick R, Hendy J, Newman S. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ 2012, 344:e3874. 10.1136/bmj.e3874, 3381047, 22723612.
17. National Board of eHealth National Strategy for Digitalisation of the Danish Healthcare Sector 2013-2017 2013, Copenhagen: , National Board of eHealth.
18. Global initiative for Chronic Obstructive Lung disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013, [http://www.goldcopd.com], Global initiative for Chronic Obstructive Lung disease (GOLD).
19. Dinesen B, Haesum LKE, Soerensen N, Nielsen C, Grann O, Hejlesen O, Toft E, Ehlers LH. Using preventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients. J Telemed Telecare 2012, 18:221-225. 10.1258/jtt.2012.110704, 22653618.
20. Bentsen SB, Rokne B, Wahl AK. Comparison of health-related quality of life between patients with chronic obstructive pulmonary disease and the general population. Scand J Caring Sci 2013, 27:905-912. 10.1111/scs.12002, 23121503.
21. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ 2012, 345:e5661-e5661. 10.1136/bmj.e5661, 22951546.
22. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 339:b2393.
23. Wittrup-Jensen K, Lauridsen J, Gudex C, Pedersen K. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health 2009, 37:459-466. 10.1177/1403494809105287, 19411320.
24. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. Third edit 2005, New York: Oxford University Press.
25. Work Productivity and Activity Impairment Questionnaire. [http://www.reillyassociates.net/WPAI_General.html].
26. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation 2006, New York: Oxford University Press.
27. Glick H, Doshi J, Sonnad S, Polsky D. Economic Evaluation in Clinical Trials 2007, New York: Oxford University Press.